NEW YORK (GenomeWeb) – The US Patent and Trademark Office appeals board has invalidated certain claims on a patent held by Illumina that is the subject of an infringement lawsuit by the company against Qiagen's Intelligent Bio-Systems.

It is unclear what effect Tuesday's final decision by the Patent Trial and Appeal Board will have on the lawsuit. Both Illumina and Qiagen declined to comment citing ongoing litigation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.